Healthcare Analysis of European Hepatitis B and C Diagnostics Market

Increase in High-risk Group Prevalence Boosts Market Growth

INDUSTRY
Healthcare

RELEASE DATE
18-Dec-2012
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
M8ED-01-00-00-00
SKU
HC01993-EU-MR_07251
Yes
SHARE

Analysis of European Hepatitis B and C Diagnostics Market
Published on: 18-Dec-2012 | SKU: HC01993-EU-MR_07251

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The unmet need to develop cost-effective diagnostic tests to distinguish acute and chronic hepatits cases has created an opportunity among market participants. This research service analyses the Hepatitis B and C diagnostics markets in Europe, particularly, Hepatitis B NAT diagnostics, Hepatitis B Immunodiagnostics, Hepatitis C NAT diagnostics and Hepatitis C Immunodiagnostics. It provides an overview, revenue forecasts, Market Engineering measurements, key trends and product profiles, along with strategic recommendations. The regional market analysis includes the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. The period covered in the study is 2009–2019, with base year 2012.

Executive Summary of the Hepatitis B and C Diagnostics Market

  • Title Slide
  • Research Team
  • Contents
  • List of Figures
  • List of Charts
  • Executive Summary
  • Executive Summary—Market Engineering Measurements
  • Executive Summary—CEO’s Perspective

Market Overview

  • Market Overview—Definitions
  • Market Overview—Key Questions This Study Will Answer
  • Market Overview—Market Segmentation
  • Market Overview—Geographic Segmentation

External Challenges: Drivers and Restraints—Hepatitis B and C Diagnostics Market

  • Drivers and Restraints
  • Drivers Explained
  • Restraints Explained
  • Impact Mapping of Drivers and Restraints

Market Overview of the Hepatitis B Diagnostics Market

Forecasts and Trends—Hepatitis B Diagnostics Market

Market Share and Competitive Analysis— Hepatitis B Diagnostics Market

  • Market Overview—Hepatitis B Diagnostics Market

Hepatitis B NAT Diagnostics Segment Breakdown

  • Market Engineering Measurements
  • Forecast Assumptions
  • Hepatitis B Diagnostics Market—Revenue Forecast
  • Hepatitis B Diagnostics Market—Revenue Forecast by Segment
  • Revenue Forecast Discussion
  • Hepatitis B Diagnostics Market—Metrics Analysis

Hepatitis B Immunodiagnostics Segment Breakdown

  • Competitive Analysis
  • Competitive Environment

Regional Analysis—Hepatitis B Diagnostics Market

  • Segment Overview—Hepatitis B NAT Diagnostics
  • Product Profile

Market Overview of the Hepatitis C Diagnostics Market

Forecasts and Trends—Hepatitis C Diagnostics Market

Market Share and Competitive Analysis—Hepatitis C Diagnostics Market

Hepatitis C NAT Diagnostics Segment Breakdown

Hepatitis C Immunodiagnostics Segment Breakdown

Regional Analysis—Hepatitis C Diagnostics Market

Conclusions and Strategic Recommendations

The Last Word

Appendix


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

25 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...

23 Sep 2026   |   Global   |   Technology Research

Programmable Epigenome Editing for Disease Reversal

Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...

21 Sep 2026   |   Europe   |   Market Research

HLTH Europe 2026: Five Key Takeaways and Growth Opportunities

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...

21 Sep 2026   |   Global   |   Frost Radar

Frost Radar: Smart Nutraceuticals for Brain Health, 2026

This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...

18 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026

Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The unmet need to develop cost-effective diagnostic tests to distinguish acute and chronic hepatits cases has created an opportunity among market participants. This research service analyses the Hepatitis B and C diagnostics markets in Europe, particularly, Hepatitis B NAT diagnostics, Hepatitis B Immunodiagnostics, Hepatitis C NAT diagnostics and Hepatitis C Immunodiagnostics. It provides an overview, revenue forecasts, Market Engineering measurements, key trends and product profiles, along with strategic recommendations. The regional market analysis includes the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. The period covered in the study is 20092019, with base year 2012.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Srinivas Sashidhar
Industries Healthcare
WIP Number M8ED-01-00-00-00
Is Prebook No

Analysis of European Hepatitis B and C Diagnostics Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01993-EU-MR_07251